Skip to main content

Table 1 Basic characteristics of included studies and literature quality evaluation table

From: Prognostic effect of atrial fibrillation on survival in patients with hypertrophic cardiomyopathy: a meta-analysis

study

country

Study type

Follow-up time(year)

Diagnosis mode of atrial fibrillation

Sample Size(AF+/AF-)

age(y)

male(%)

NOS score

Min-Tsun,2021

China,Taiwan

Case-control study

8.5

ICD-9CM

1169/9741

62 ± 13

52.5

8

Robinson,1990

UK

Retrospective cohort study

7

physical examination、dynamic electrocardiogram

52/122

NR

55.7

6

Konstantinos, 2014

USA

Retrospective cohort study

6.1

electrocardiogram

650/3023

55 ± 16

55

7

Tian, 2013

China

Case-control study

4.2

ultrasound cardiogram

112/542

50 ± 15

71

8

Maron,2000

USA

Prospective cohort study

8

ultrasound cardiogram

153/591

NR

62

8

Lee,2017

Korea

Retrospective cohort study

5.5

ultrasound cardiogram

77/229

62 ± 11

NR

8

Iacopo,2001

Italy/USA

Prospective cohort study

9.1

electrocardiogram

107/373

55 ± 15

NR

8

Higashikawa,1997

Japan

Retrospective cohort study

5

ultrasound cardiogram

19/64

50.3 ± 13.9/55.5 ± 7.8

72.3

6

Milind,2015

USA

Prospective cohort study

8.1

ultrasound cardiogram

282/1247

50 ± 13

63

7

Song,2013

China

Case-control study

0.5–0.8

ultrasound cardiogram

123/344

51.8 ± 13.1/48.5 ± 16.0

56

8

Hyun-Jung,2020

Korea

Case-control study

2.5

ICD-10CM

1169/7180

60.7 ± 11.9

69.2

9

  1. AF+: patients with atrial fibrillation; AF-: patients without atrial fibrillation; NOS: Newcastle-Ottawa Scale; NR: not reported; ICD-9CM: International Classification of Disease Ninth Revision Clinical Modification codes; ICD-10CM: International Classification of Disease Tenth Revision Clinical Modification codes; NOS: Newcastle-Ottawa Scale